Gregory J, Tselikas L, Allimant C, de Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M. Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study. Eur J Nucl Med Mol Imaging. 2023;50(3):921–8. https://doi.org/10.1007/s00259-022-06002-5.

Article  PubMed  Google Scholar 

Braat AJAT, Smits MLJ, Braat MNGJA, van den Hoven AF, Prince JF, de Jong HWAM, van den Bosch MAAJ, Lam MGEH. 90Y Hepatic radioembolization: an update on current practice and recent developments. J Nucl Med. 2015;56(7):1079–87. https://doi.org/10.2967/jnumed.115.157446.

Article  PubMed  Google Scholar 

Salem R, Padia SA, Lam M, Bell J, Chiesa C, Fowers K, et al. Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2019;46:1695–704. https://doi.org/10.1007/s00259-019-04340-5.

Article  PubMed  Google Scholar 

Keane G, de Jong HWAM, Lam MGEH. Beyond the MAA-Y90 paradigm: the evolution of radioembolization dosimetry approaches and scout particles. Semin Interv Radiol. 2021;38(5):542–53. https://doi.org/10.1055/s-0041-1736660.

Article  Google Scholar 

Reinders MTM, Mees E, Powerski MJ, Bruijnen RCG, van den Bosch MAAJ, Lam MGEH, Smits MLJ. Radioembolisation in Europe: a survey amongst CIRSE members. Cardiovasc Intervent Radiol. 2018;41(10):1579–89. https://doi.org/10.1007/s00270-018-1982-4.

Article  PubMed  PubMed Central  Google Scholar 

Powerski MJ, Scheurig-Munkler C, Banzer J, Schnapauff D, Hamm B, Gebauer B. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centres in Europe. Eur J Radiol. 2012;81(7):e804–11. https://doi.org/10.1016/j.ejrad.2012.04.004.

Article  PubMed  Google Scholar 

Helmberger T, Golfieri R, Pech M, Pfammatter T, Arnold D, Cianni R, Maleux G, Munneke G, Pellerin O, Peynircioglu B, Sangro B, Schaefer N, de Jong N, Bilbao JI. Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the prospective multicentre observational study CIRSE registry for SIR-spheres therapy (CIRT). Cardiovasc Intervent Radiol. 2021;44(1):21–35. https://doi.org/10.1007/s00270-020-02642-y.

Article  PubMed  Google Scholar 

Kim HC, Lee M, Lee JH, Paeng JC, Kim YJ, Chung JW. Combination of 1st and 2nd week dosing of glass yttrium-90 microspheres for superselective radioembolization. in Vivo. 2020;34(5):2763–8. https://doi.org/10.21873/invivo.12100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sjögreen Gleisner K, Spezi E, Solny P, et al. Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey. EJNMMI Phys. 2017;4:28. https://doi.org/10.1186/s40658-017-0193-4.

Article  PubMed  PubMed Central  Google Scholar 

Rojas B, Hooker C, McGowan DR, Guy MJ, Tipping J. Eight years of growth and change in UK molecular radiotherapy with implications for the future: internal dosimetry users group survey results from 2007 to 2015. Nucl Med Commun. 2017;38(3):201–4. https://doi.org/10.1097/MNM.0000000000000642.

Article  PubMed  Google Scholar 

Alonso JC, Casans I, González FM, Fuster D, Rodríguez A, Sánchez N, Oyagüez I, Burgos R, Williams AO, Espinoza N. Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review. BMC Gastroenterol. 2022;22:326. https://doi.org/10.1186/s12876-022-02396-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18(12):1624–36. https://doi.org/10.1016/S1470-2045(17)30683-6.

Article  CAS  PubMed  Google Scholar 

Chow PKH, Gandhi M, Tan SB, Khin MW, Khasbazar A, Ong J, et al. SIRveNIB: Selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma. J Clin Oncol. 2018;36(19):1913–21. https://doi.org/10.1200/JCO.2017.76.0892.

Article  CAS  PubMed  Google Scholar 

Ricke J, Klümpen HJ, Amthauer H, Bargellini I, Bartenstein P, de Toni EN, Gasbarrini A, Pech M, Peck-Radosavljevic M, Popovič P, Rosmorduc O, Schott E, Seidensticker M, Verslype C, Sangro B, Malfertheiner P. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma. J Hepatol. 2019;71(6):1164–74. https://doi.org/10.1016/j.jhep.2019.08.006.

Article  CAS  PubMed  Google Scholar 

van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, et al. SIRFLOX: randomized phase iii trial comparing first-line mfolfox6 (plus or minus bevacizumab) versus mfolfox6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol. 2016;34(15):1723–31. https://doi.org/10.1200/JCO.2015.66.1181.

Article  CAS  PubMed  Google Scholar 

Dutton SJ, Kenealy N, Love SB, Wasan HS, Sharma RA. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. BMC Cancer. 2014;14:497. https://doi.org/10.1186/1471-2407-14-497.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hermann AL, Dieudonné A, Ronot M, Sanchez M, Pereira H, Chatellier G, Garin E, Castera L, Lebtahi R, Vilgrain V. Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study. Radiology. 2020;296(3):673–84. https://doi.org/10.1148/radiol.2020191606.

Article  PubMed  Google Scholar 

de Baere T, Crocetti L. Radioembolization: same player shoots again. Cardiovasc Intervent Radiol. 2022;45:1577–8. https://doi.org/10.1007/s00270-022-03269-x.

Article  PubMed  Google Scholar 

Rojas B, McGowan DR, Gear J, Smith AL, Scott C, Craig AJ, Scuffham J, Towey D, Aldridge M, Tipping J. Nearly double the patients and dramatic changes over 14 years of UK MRT: Internal Dosimetry Users Group survey results from 2007 to 2021. Nucl Med Commun. 2023. https://doi.org/10.1097/MNM.0000000000001780.

Article  PubMed  PubMed Central  Google Scholar 

Cutler CS, Bailey E, Kumar V, Schwarz SW, Bom HS, Hatazawa J, Paez D, Orellana P, Louw L, Mut F, Kato H, Chiti A, Frangos S, Fahey F, Dillehay G, Oh SJ, Lee DS, Lee ST, Nunez-Miller R, Bandhopadhyaya G, Pradhan PK, Scott AM. Global issues of radiopharmaceutical access and availability: a nuclear medicine global initiative project. J Nucl Med. 2021;62(3):422–30. https://doi.org/10.2967/jnumed.120.247197.

Article  PubMed  PubMed Central  Google Scholar 

Ghosh A, Zhang J, Akhter NM. Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma. J Clin Imaging Sci. 2022;12(12):27. https://doi.org/10.25259/JCIS_213_2021.

Article  PubMed  PubMed Central  Google Scholar 

Liu LB, Cedillo MA, Bishay V, Ranade M, Patel RS, Kim E, Nowakowski SF, Lookstein RA, Fischman AM. Patient experience and preference in transradial versus transfemoral access during transarterial radioembolization: a randomized single-center trial. J Vasc Interv Radiol. 2019;30(3):414–20. https://doi.org/10.1016/j.jvir.2018.10.005.

Article  PubMed  Google Scholar 

Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, Fowers K, Lewandowski R, Padia SA. Yttrium-90 Radioembolization for the Treatment of Solitary, unrespectable HCC: the LEGACY study. Hepatology. 2021;74(5):2342–52. https://doi.org/10.1002/hep.31819.

Article  CAS  PubMed  Google Scholar 

Kim E, Sher A, Abboud G, Schwartz M, Facciuto M, Tabrizian P, Knešaurek K, Fischman A, Patel R, Nowakowski S, Llovet J, Taouli B, Lookstein R. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study. Lancet Gastroenterol Hepatol. 2022;7(9):843–50. https://doi.org/10.1016/S2468-1253(22)00091-7.

Article  PubMed  Google Scholar 

Lionberg A, Nijhawan K, Navuluri R, Zangan S, Van Ha T, Funaki B, Ahmed O. Hybrid angiography-CT for transarterial radioembolization: a pictorial essay. Abdominal Radiol (NY). 2021;46(6):2850–4. https://doi.org/10.1007/s00261-020-02914-8.

Article  Google Scholar 

Hamami ME, Poeppel TD, Müller S, Heusner T, Bockisch A, Hilgard P, Antoch G. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med. 2009;50(5):688–92. https://doi.org/10.2967/jnumed.108.058347.

Article  CAS  PubMed